US Government Cracks Down on Clinical-Trials Reporting
By Sara Reardon,
Nature News
| 11. 19. 2014
Untitled Document
Hiding negative results and harmful side effects that occur in clinical trials would become harder in the United States under regulations proposed on 19 November by the US National Institutes of Health (NIH) and the Food and Drug Administration (FDA).
One proposal would require companies seeking the FDA’s approval of a new drug or therapy to post all clinical-trial results to the government website ClinicalTrials.gov, even if the treatment being tested is never approved; current law mandates this only for drugs that are approved. Companies and researchers that do not comply with the deadlines set out in the proposal could face fines of US$10,000 per day.
The second proposal would require that any NIH-funded research on interventions, not just drugs, be registered and reported on ClinicalTrials.gov. The rule would apply to surgical techniques and behavioural interventions such as anti-smoking programmes.
And for the first time, federally funded researchers will be required to post the results of their phase I clinical trials. Noncompliant institutions could have their NIH funding withdrawn.
The regulations are intended to close a loophole in...
Related Articles
By Gaby Del Valle, Politico | 04.28.2024
Photo by Rob Curran from Unsplash
The threat, we are told here this weekend, is existential, biological, epoch-defining. Economies will fail, civilizations will fall, and it will all happen because people aren’t having enough babies.
“The entire global financial system...
By Osagie K. Obasogie, L.A. Review of Books | 04.17.2024
When Robert G. Edwards won the Nobel Prize in Physiology or Medicine in 2010 for developing in vitro fertilization (IVF) decades earlier in 1978, many members of the scientific community sighed in relief. This honor, they felt, was long...
By Alex Philippidis, Genetic Engineering & Biotechnology News | 05.07.2024
Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death of a young boy who received the treatment last year.
The boy, whose age was...
By Lauren Quinn, Hazlitt | 05.01.2024
“It hurt,” my friend told me. “They don’t tell you that it hurts.”
Her voice came heavy through my headphones as I scrubbed the dinner dishes. “Like, I could feel the needle going through all the layers—skin, fat, muscle—and I could...